# Critical Review: User Needs - Kosmos RCT Testing

## Executive Summary
The user needs document makes strong assumptions about a narrowly-defined user persona without validation evidence. While it identifies plausible pain points, there's no data supporting these are the actual needs of Schmidt Sciences RCT participants. The document reads as designed to justify testing Kosmos rather than genuinely understanding user requirements.

## Fatal Flaws (Must Fix Before Execution)

1. **No User Validation**
   - **Problem:** All user needs, pain points, and success factors appear to be assumed rather than validated with actual Schmidt Sciences RCT participants
   - **Impact:** May build tests for the wrong use cases, leading to false validation or missing critical user requirements
   - **Evidence:** No mention of user interviews, surveys, or consultation with actual early-career computational biologists
   - **Fix:** Conduct 3-5 interviews with Schmidt Sciences grant applicants to validate assumptions. Document their actual proposal-writing workflow and pain points.

2. **"Zero Fabricated Citations" Success Criterion Undefined**
   - **Problem:** Listed as a "deal-breaker" but no verification methodology specified here
   - **Impact:** Critical success factor cannot be measured without defined verification process
   - **Evidence:** States "Zero fabricated citations" but doesn't say how this will be verified or what constitutes "fabricated"
   - **Fix:** Define verification methodology (CrossRef API spot-checking? Manual review? What sample size?). Specify threshold (5% fabrication rate? 1%? Zero tolerance?).

3. **Unrealistic Speed Expectations**
   - **Problem:** "Complete proposal-relevant tasks in minutes, not days" combined with "Enable 2-week proposal timeline" is contradictory to actual grant writing reality
   - **Impact:** Setting up for failure if Kosmos outputs require significant human review/editing time
   - **Evidence:** Most competitive grant proposals take months, not 2 weeks. Schmidt Sciences may have specific timeline - but is it validated?
   - **Fix:** Confirm actual Schmidt Sciences proposal timeline from program documentation. Clarify what "proposal-relevant tasks" means (entire proposal? just background section? specific analyses?).

## Serious Issues (High Risk)

1. **Overly Narrow Persona**
   - **Problem:** Focuses exclusively on "early-career computational biologists" - excludes experimentalists, mid-career researchers, clinicians
   - **Likelihood:** High - RCT likely has diverse participant backgrounds
   - **Impact:** Tests may validate Kosmos for narrow use case but miss broader applicability (or lack thereof)
   - **Mitigation:** Expand persona to include at least one additional user type (e.g., "experimental biologist with limited comp skills"). Test with both personas.

2. **"Publication-Ready" is Extremely Vague**
   - **Problem:** "Publication-ready figures/analyses" is subjective and sets extremely high bar without definition
   - **Likelihood:** High - figures will likely need significant editing
   - **Impact:** Unrealistic expectations lead to pilot "failure" even if outputs are useful
   - **Mitigation:** Define specific criteria for "publication-ready" (axes labeled? Legends present? Statistical annotations? Specific journal style?) or downgrade to "draft-quality visualizations".

3. **"No Additional Verification Burden" Conflicts with Reality**
   - **Problem:** Success factor states "No additional verification burden" but earlier states "Zero fabricated citations" as deal-breaker
   - **Likelihood:** Very high - researchers will always verify AI-generated content
   - **Impact:** Creates impossible success criterion
   - **Mitigation:** Reframe as "Minimal verification burden - spot-checking rather than full validation" and quantify (e.g., "verify 5% of citations rather than 100%").

## Moderate Concerns (Should Address)

1. **Pain Points Lack Evidence**
   - **Problem:** "Literature overload", "Novelty uncertainty", etc. are plausible but not validated
   - **Impact:** May optimize for wrong problems
   - **Recommendation:** Survey or interview 5-10 recent Schmidt applicants: "What took the most time in your proposal?" vs. "What was most difficult?"

2. **Domain Coverage May Be Insufficient**
   - **Problem:** Lists 5 domains (cancer, immuno, systems bio, structural bio, neuro) but comp bio spans many more
   - **Impact:** Pilot may miss important domains where Kosmos fails (e.g., ecology, evolutionary bio, agricultural genomics)
   - **Recommendation:** Justify why these 5 domains are representative. Consider adding 1-2 edge cases.

3. **Non-Goals May Exclude Critical Features**
   - **Problem:** "Multi-investigator collaboration features" excluded, but many proposals are collaborative
   - **Impact:** May discover Kosmos is useful individually but fails for team proposals
   - **Recommendation:** Document whether Schmidt Sciences proposals are individual or team-based. If team-based, reconsider non-goal.

4. **Success Timeline Disconnect**
   - **Problem:** User needs focused on "2-week proposal timeline" but PRD shows 4-hour pilot
   - **Impact:** Testing wrong timescale - 4 hours doesn't validate 2-week workflow
   - **Recommendation:** Clarify relationship between 4-hour pilot and 2-week proposal process. Pilot should test representative subtasks, not full workflow.

## Minor Issues (Nice to Have)

1. **"Actionability" Undefined**
   - **Problem:** "Direct integration into grant proposals" - what does this mean technically?
   - **Recommendation:** Specify format requirements (LaTeX? Word? Markdown?). Does output copy-paste cleanly?

2. **Chemistry Knowledge Gap Assumption**
   - **Problem:** Assumes "Biologists lack cheminformatics expertise" - may not apply to all users
   - **Recommendation:** Validate this assumption for Schmidt cohort specifically.

## Strengths (What's Good)

1. **Clear Primary Goal** - 2-hour pilot scope is well-defined
2. **Specific Critical Success Factors** - Speed, Accuracy, Actionability, Coverage are good dimensions
3. **Explicit Non-Goals** - Helps scope the pilot appropriately
4. **Diverse Task Types** - Recognizes proposals need literature + data + precedent + chemistry

## Unanswered Questions

1. **Who are the actual Schmidt Sciences RCT participants?** Demographics, career stage, institutional resources?
2. **What is the actual Schmidt Sciences proposal structure?** Sections, page limits, required components?
3. **How were these pain points identified?** Literature review? Anecdotal? Prior surveys?
4. **What happens if a user needs wet lab protocols?** Excluded as non-goal but may be essential for proposals.
5. **How do we define "novel" for hypothesis novelty validation?** Novel in last 1 year? 5 years? Globally?
6. **What if computational biology isn't the right framing?** Schmidt Sciences may fund interdisciplinary work beyond comp bio.

## Recommended Changes

- [ ] Interview 3-5 Schmidt Sciences participants to validate user needs
- [ ] Obtain actual Schmidt Sciences proposal guidelines and timeline requirements
- [ ] Define "publication-ready" with measurable criteria or remove term
- [ ] Replace "Zero fabricated citations" with specific verification methodology and tolerance
- [ ] Clarify "No additional verification burden" â†’ "Minimal verification burden (spot-check only)"
- [ ] Add evidence source for each pain point (interview quote, survey data, or mark as "assumed")
- [ ] Justify why 5 chosen domains are representative of Schmidt Sciences work
- [ ] Document whether proposals are individual or collaborative

## Overall Risk Assessment

**Execution Risk:** Medium - Can proceed with pilot but may test wrong use cases
**Scientific Validity Risk:** High - User needs not validated with real users
**Timeline Risk:** Low - Document doesn't drive timeline, just describes user context
**Budget Risk:** Low - No budget implications in this document

## Verdict

**GO WITH CONDITIONS**

This document provides a reasonable starting hypothesis for user needs, but lacks validation. The pilot can proceed since it's exploratory, but findings should be interpreted cautiously. Major condition: Before full RCT deployment, validate these assumptions with actual Schmidt participants through interviews or surveys. Minor conditions: Define measurable criteria for subjective terms like "publication-ready" and "zero fabricated citations".

The narrow persona (early-career comp bio only) is the biggest risk - if Schmidt cohort is more diverse, pilot results won't generalize. Confirm participant demographics before finalizing test design.
